Navigation Links
Hospira Reports Fourth-Quarter and Full-Year 2010 Results
Date:2/2/2011

LAKE FOREST, Ill., Feb. 2, 2011 /PRNewswire/ -- Hospira, Inc. (NYSE: HSP), a leading global specialty pharmaceutical and medication delivery company, today reported results for the fourth quarter and full year ended Dec. 31, 2010. For the fourth quarter of 2010, net sales were $992 million, and adjusted* diluted earnings per share were $0.77. For full-year 2010, net sales were $3.9 billion, and adjusted* diluted earnings per share were $3.31. (Adjusted* measures exclude certain specified items as described later in this press release and the attached schedules.)

"2010 marked a year of progress for Hospira, despite several unanticipated challenges," said Christopher B. Begley, chairman and chief executive officer. "We launched gemcitabine, a large oncology drug, in the United States during the fourth quarter, the first generic version of the drug in the market; we expanded both our operations and portfolio geographically; we made substantial progress with our quality initiatives; and we met our commitments with Project Fuel, our corporate-wide optimization initiative. Looking forward, we expect a year of good growth in 2011, as we remain committed to transforming challenges into opportunities and driving continuous improvement across the organization."

Fourth-Quarter 2010 Results

The following table highlights selected financial results for the fourth quarter of 2010 compared to the same period in 2009:

In $ millions, GAAP Adjusted* except per Three Months Ended Three Months Ended share amounts Dec. 31, Dec. 31, ------------------ % ------------------ % 2010 2009 Change 2010 2009 Change ------ ------- ------ ------ ------ ------ Net Sales $992.1 $1,055.2 (6.0)% n/a n/a n/a Gross Profit (Net Sales less Cost of Products Sold) $347.9 $395.0 (11.9)% $388.1 $427.5 (9.2)% Income from Operations $53.6 $135.6 (60.5)% $141.6 $204.2 (30.7)% Diluted EPS $0.36
'/>"/>

SOURCE Hospira, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19

Related medicine technology :

1. Hospira to Host Conference Call for Fourth-Quarter 2010 Results and 2011 Projections
2. Hospira Launches Piperacillin and Tazobactam for Injection in the United States
3. Hospira Announces New Contracts in Effect with Novation for Infusion Pumps, Solutions and Equipment
4. Hospira to Host Conference Call for Third-Quarter 2010 Results
5. Hospira Receives TGA Approval for Nivestim™, Australias First Biosimilar Filgrastim
6. Hospira Japan Receives Approval for New Indication for Precedex IV™ 200ug
7. Hospira Announces CEO Succession Plan
8. Hospira to Present at Bank of America Merrill Lynch 2010 Specialty Pharmaceuticals Conference Aug. 12
9. Hospira Begins Phase I U.S. Clinical Trial of Biosimilar Erythropoietin in Renal Patients
10. Hospira TheraDoc(TM) Infection Control Assistant(TM) Documents Interventions to Help Hospital Reduce Catheter-Related Infections
11. Hospira Announces Intention to Complete Tender Offer for Shares of Javelin Pharmaceuticals
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/19/2014)... 19, 2014 You,re visiting the dentist for ... when he or she says you need a root ... you may have several questions and feel apprehensive about ... know it,s nothing to worry about. The Pennsylvania Dental ... alleviate any anxiety the public may have surrounding this ...
(Date:12/19/2014)... , Dec. 19, 2014 In ... research and marketing communication tools are essential for ... competitive – consequently consumers, desires, preferences, and unmet ... environment, market research groups across all industries are ... communication tools. However, the adoption of new market ...
(Date:12/19/2014)... , Dec. 18, 2014 Research and Markets ... addition of the "Micro Market Monitor: North ... their offering. http://photos.prnewswire.com/prnh/20130307/600769 ... is progressing steadily, which has resulted in fueling ... market. The main purpose of these dermatology devices ...
Breaking Medicine Technology:Root Canals Have Become More Routine 2Study Uncovers New Tools and Techniques for Understanding Consumer Decision Making 2Micro Market Monitor: North American Dermatology Diagnostic Devices Market 2Micro Market Monitor: North American Dermatology Diagnostic Devices Market 3
... Nov. 1, 2011 Daylight Saving Time comes to an end ... altering sleep patterns. Sixty percent of Americans say that they experience ... the National Sleep Foundation,s 2011 Sleep in America poll, and for ... This season, fall back into bed for not only ...
... Calif., Nov. 1, 2011 Telik, Inc. (Nasdaq: ... studies on Telintra and related analogs at the 2011 ... and Cancer Therapeutics in San Francisco, California.  Details of ... Novel Ezatiostat analogues disrupt binding of GSTP1 to ...
Cached Medicine Technology:Keep the Time Change From Disrupting Your Rest With Sleep Formula 39™ 2Telik Announces Ezatiostat (Telintra®) Preclinical Presentation at the 2011 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics 2
(Date:12/21/2014)... York, New York (PRWEB) December 21, 2014 ... ) and other product liability claims involving a ... incretin mimetics continue to move forward in a ... Court, Southern District of California, Bernstein Liebhard LLP ... the Court has established a data cut-off date ...
(Date:12/21/2014)... Serious Buyer, Andrew Hawley from Vintage ... and the Doors International Ballroom at the Hilton Hotel ... the only time that Morrison's mother would see her ... 1967. According to Hawley, “This would be the Doors ... Alexandria Roller Rink earlier that year and would return ...
(Date:12/21/2014)... As testosterone therapy lawsuit filings ... and blood clots from using testosterone products such as ... shows that the male hormone testosterone may increase the ... published in the Proceedings of the National Academy of ... group of male rats with naturally occurring colon cancer. ...
(Date:12/20/2014)... BambooIndustry.com is a leading eco-friendly bamboo ... its bamboo flooring promotion for the coming 2015. ... suppliers, and offers the best bamboo products and ... promotion, all customers can enjoy a special discount, ... know BambooIndustry.com from press releases. , The bamboo ...
(Date:12/20/2014)... New York, NY (PRWEB) December 20, 2014 ... ) that allege a metal-on-metal version of the ... move forward in state and federal courts, Bernstein ... in New Jersey’ Bergen County Superior Court on ... were permitted to begin deposition of plaintiffs on ...
Breaking Medicine News(10 mins):Health News:Byetta Lawsuit News: New Order Issued in Federal Incretin Mimetics Litigation, Bernstein Liebhard LLP Report 2Health News:Byetta Lawsuit News: New Order Issued in Federal Incretin Mimetics Litigation, Bernstein Liebhard LLP Report 3Health News:Byetta Lawsuit News: New Order Issued in Federal Incretin Mimetics Litigation, Bernstein Liebhard LLP Report 4Health News:New Low Testosterone Therapy Study Shows Male Hormone Testosterone May Contribute To Colon Cancer Reports Wright & Schulte LLC 2Health News:New Low Testosterone Therapy Study Shows Male Hormone Testosterone May Contribute To Colon Cancer Reports Wright & Schulte LLC 3Health News:New Low Testosterone Therapy Study Shows Male Hormone Testosterone May Contribute To Colon Cancer Reports Wright & Schulte LLC 4Health News:Eco-friendy Bamboo Flooring Manufacturer BambooIndustry.com Introduces Its Bamboo Flooring Promotion for 2015 2Health News:New Jersey Court Overseeing DePuy Pinnacle Hip Lawsuits Issues New Order, Bernstein Liebhard LLP Reports 2Health News:New Jersey Court Overseeing DePuy Pinnacle Hip Lawsuits Issues New Order, Bernstein Liebhard LLP Reports 3Health News:New Jersey Court Overseeing DePuy Pinnacle Hip Lawsuits Issues New Order, Bernstein Liebhard LLP Reports 4
... premier educational gathering of the world,s leading laser experts hosted by ... ... Wausau, WI (PRWEB) November 20, 2008 -- The American Society ... National Harbor, Md., April 1 - 5, 2009     , , ...
... California reorganization plans , , ... this week in an advisory vote on two reorganization plans. ... whether they want to be part of a new single ... representing a broader classification of healthcare workers. , ...
... cancer survival are largely inaccurate because they widely disregard ... in addition to their primary cancer, says Jay Piccirillo, ... School of Medicine in St. Louis, the Siteman Cancer ... problem with cancer survival statistics, which generally don,t take ...
... Cyberonics, Inc. (Nasdaq: CYBX ),today announced results for the quarter ... , Results for the second quarter of ... , -- Net sales of $36.0 million, a 24% increase ... the epilepsy indication, increased by an estimated ...
... and slows the progression of AIDS, study confirms , , ... finalizes research that changed guidelines around the world regarding ... on preliminary findings released last year, several health agencies ... begin HIV treatment early in babies, instead of waiting ...
... congressional breakfast briefing on the subject of civic engagement ... as the closing session of the 61st Annual Scientific ... President-Elect Barack Obama has voiced support for an expanded ... are preparing to work quickly with congressional leaders to ...
Cached Medicine News:Health News:Announcing a Monumental Sharing of Laser Innovation: The American Society for Laser Medicine and Surgery (ASLMS) Holds 29th Annual Conference in National Harbor, Md., April 1 - 5, 2009 2Health News:Advisory Vote Begins on California Long-Term Care Local 2Health News:Survival of head and neck cancer patients is greatly affected by coexisting ailments 2Health News:Survival of head and neck cancer patients is greatly affected by coexisting ailments 3Health News:Cyberonics Reports Strong Sales Growth and Profitability in Fiscal 2009 Second Quarter 2Health News:Cyberonics Reports Strong Sales Growth and Profitability in Fiscal 2009 Second Quarter 3Health News:Cyberonics Reports Strong Sales Growth and Profitability in Fiscal 2009 Second Quarter 4Health News:Cyberonics Reports Strong Sales Growth and Profitability in Fiscal 2009 Second Quarter 5Health News:Cyberonics Reports Strong Sales Growth and Profitability in Fiscal 2009 Second Quarter 6Health News:Cyberonics Reports Strong Sales Growth and Profitability in Fiscal 2009 Second Quarter 7Health News:Cyberonics Reports Strong Sales Growth and Profitability in Fiscal 2009 Second Quarter 8Health News:Cyberonics Reports Strong Sales Growth and Profitability in Fiscal 2009 Second Quarter 9Health News:Cyberonics Reports Strong Sales Growth and Profitability in Fiscal 2009 Second Quarter 10Health News:Early HIV Treatment Best for Babies 2
... High Density, multi-frequency, linear flexible ... on the UST-5536, this "Omni-Plane ... sweeps horizontally as well as ... so that target lesions can ...
Super High Density, multi-frequency, end-fire phased array transducer. Point-and-shoot scanning is the benefit of this transducer....
This is a 3D transducer for endovaginal imaging in OB/GYN....
This is a 3D transducer for endovaginal imaging in OB/GYN....
Medicine Products: